Targets for indole-3-carbinol in cancer prevention

被引:196
作者
Kim, YS [1 ]
Milner, JA [1 ]
机构
[1] NCI, Div Canc Prevent, Nutr Sci Res Grp, Bethesda, MD 20892 USA
关键词
indole-3-carbinol; estrogen receptor; aryl hydrocarbon receptor; Spl;
D O I
10.1016/j.jnutbio.2004.10.007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mounting preclinical and clinical evidence indicate that indole-3-carbinol (I3C), a key bioactive food component in cruciferous vegetables, has multiple anticarcinogenic and antitumorigenic properties. Evidence that p21, p27, cyclin-dependent kinases, retinoblastoma, Bax/Bcl-2, cytochrome P-450 1Al and GADD153 are targets for I3C already exists. Modification of nuclear transcription factors including Sp1, estrogen receptor, nuclear factor kappaB and aryl hydrocarbon receptor may represent a common site of action to help explain downstream cellular responses to dietary I3C and, ultimately, to its anticancer properties. While the current information is intriguing, future I3C research needs to focus on why these changes in nuclear transcription factors occur and how they relate to phenotypic responses and the quantity and duration of exposure to I3C and its dimer 3,3'-diindolylmethane. Published by Elsevier Inc.
引用
收藏
页码:65 / 73
页数:9
相关论文
共 74 条
[1]   Small inhibitory RNA duplexes for Sp1 mRNA block basal and estrogen-induced gene expression and cell cycle progression in MCF-7 breast cancer cells [J].
Abdelrahim, M ;
Samudio, I ;
Smith, R ;
Burghardt, R ;
Safe, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (32) :28815-28822
[2]   Modulation of vinca-alkaloid induced P-glycoprotein expression by indole-3-carbinol [J].
Arora, A ;
Shukla, Y .
CANCER LETTERS, 2003, 189 (02) :167-173
[3]  
Ashok BT, 2002, EUR J CANCER PREV, V11, pS86
[4]  
Ashok BT, 2001, NUTR CANCER, V41, P180, DOI 10.1207/S15327914NC41-1&amp
[5]  
2_25
[6]  
BEIER RC, 1990, REV ENVIRON CONTAM T, V113, P47
[7]   Placebo-controlled trial of indole-3-carbinol in the treatment of CIN [J].
Bell, MC ;
Crowley-Nowick, P ;
Bradlow, HL ;
Sepkovic, DW ;
Schmidt-Grimminger, D ;
Howell, P ;
Mayeaux, EJ ;
Tucker, A ;
Turbat-Herrera, EA ;
Mathis, JM .
GYNECOLOGIC ONCOLOGY, 2000, 78 (02) :123-129
[8]  
Bonnesen C, 2001, CANCER RES, V61, P6120
[9]  
Bradlow HI, 1996, J ENDOCRINOL, V150, pS259
[10]  
Brandi G, 2003, CANCER RES, V63, P4028